Apheresis Equipment Market Projected to Reach USD 5 Billion by 2034, Growing at a CAGR of 7.00%

The global apheresis equipment market was valued at USD 2.5 billion in 2024 and is expected to grow at a CAGR of 7.0% from 2025 to 2034. The market is driven by growing applications in therapeutic plasma exchange and blood component separation.

Market Definition

The Apheresis Equipment Market revolves around medical devices that perform extracorporeal blood separation to collect or remove specific components—such as plasma, platelets, red cells, leukocytes, or stem cells—returning the remaining blood back to the donor or patient. These systems utilize technologies like centrifugation and membrane filtration to support applications across blood donation centers, hospitals, and therapeutic settings—such as leukapheresis, plasmapheresis, stem cell harvesting, and therapeutic plasma exchange (TPE). The market covers desktop to high-capacity automated systems, including portable units, single-needle technologies, and advanced disposable kits that enhance safety and efficiency.

Key Report Highlights

The report highlights the key region that accounts for the highest revenue share in the global Apheresis Equipment market.
It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
The report outlines the dominant segment that holds a major share of the market.
It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

Market Value in 2024: USD 2.5 billion
Projected Market Size in 2034: USD 5 billion
Anticipated CAGR (2025-2034): 7.0%

Get access to the full report or request a complimentary sample for in-depth analysis:

https://www.polarismarketresearch.com/industry-analysis/global-apheresis-equipment-market/request-for-sample

Market Growth Drivers

The market is experiencing sustained growth due to several factors:

Rising chronic and autoimmune diseases: Escalating cases of conditions like leukemia, multiple sclerosis, cardiovascular disorders, and sickle cell anemia are boosting demand for therapeutic apheresis and targeted blood component treatments.
Expansion in stem cell and regenerative medicine: Apheresis is integral to hematopoietic stem cell collection for cancer and immune therapies, supported by regulatory approvals and funding.
Technological innovation and automation: AI-enhanced equipment, intelligent monitoring systems, single-needle and portable devices, and eco-friendly consumables are improving safety, efficiency, and access in outpatient and mobile settings.
Blood donation initiatives and reimbursement policies: Public awareness campaigns and favorable insurance coverage—especially in North America and Europe—are facilitating broader adoption of apheresis solutions.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include